BA
45
-3
CHD
48
-3
AMAT
43
-5
ADM
24
2
ACN
70
5
OXY
55
6
PLD
56
8
GIS
29
3
AON
60
2
WMB
68
-2
R
77
2
MMM
42
5
IFF
53
2
TAP
64
4
SIG
47
-2
DLTR
40
4
PSA
58
5
CAH
60
2
PM
58
2
ADI
45
-5
BA
45
-3
CHD
48
-3
AMAT
43
-5
ADM
24
2
ACN
70
5
OXY
55
6
PLD
56
8
GIS
29
3
AON
60
2
WMB
68
-2
R
77
2
MMM
42
5
IFF
53
2
TAP
64
4
SIG
47
-2
DLTR
40
4
PSA
58
5
CAH
60
2
PM
58
2
ADI
45
-5
Financhill
Back

Bio-Rad Laboratories 10K Form

Buy
54

BIO
Bio-Rad Laboratories

Last Price:
354.04
Seasonality Move:
7.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.67B
Cash Flow: $99.97M
Price / Cash Flow: 46.31
Annual Sales: $267.46
Price / Book: 1.36

Profitability

EPS (TTM): -27.33000
Net Income (TTM): $-778.69M
Gross Margin: $1.43B
Return on Equity: -9.62%
Return on Assets: -6.82%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 6.14
Quick Ratio: 4.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 31.78

BIO Technical Analysis vs Fundamental Analysis

Buy
54
Bio-Rad Laboratories (BIO) is a Buy

Is Bio-Rad Laboratories a Buy or a Sell?